Home Drugs COVID-19: Most-Read Stories of 2025

COVID-19: Most-Read Stories of 2025

by Newsroom


The landscape of COVID-19 shifted from a unified public health front to a complex web of regional restrictions and individual choices in 2025. As federal agencies diverged and pandemic fatigue hit record highs, the burden of clarity fell on local providers and patients alike.

Here are the most-read COVID-19 stories from Drug Topics in 2025.

CVS, Walgreens Will Limit COVID-19 Vaccine Offerings in 16 States

In September, major pharmacy chains CVS and Walgreens announced new restrictions on COVID-19 vaccine availability across 16 states, requiring prescriptions for many patients who even met the latest FDA criteria. While CVS opted out of offering the…



Source link

You may also like

About Us

Pharma Newswire™ aggregates, publishes and distributes news in the Pharmaceutical Industry. In association with EmailWire, Pharma Newswire™ provides press release distribution services in the pharmaceutical sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. To send a press release, contact us through the following messaging apps:

Pharma Newswire™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC